Skip to content

Use of Rhus toxicodendron and individualized homoeopathic medicine with and without physiotherapy in treatment of primary adhesive capsulitis of shoulder joint in 40-60 years of age group

ASSESSING THE EFFECTIVENESS OF RHUS TOXICODENDRON WITH AND WITHOUT PHYSIOTHERAPY AND INDIVIDUALISED HOMOEOPATHIC MEDICINE THROUGH KENT REPERTORY WITH AND WITHOUT PHYSIOTHERAPY IN TREATMENT OF PRIMARY ADHESIVE CAPSULITIS OF SHOULDER JOINT A COMPARATIVE STUDY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100593
Enrollment
60
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Rhus toxicodendron: To assess the effectiveness of Rhus toxicodendron with and without physiotherapy in treatment of primary adhesive capsulitis of shoulder joint. Control Intervention

Sponsors

Dr RAKSHITA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Subjects who are willing to voluntarily participate and have written informed consent. 2. Subjects of age groups 40-60 years. 3. Newly diagnosed subjects of Primary Adhesive Capsulitis.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1. Significant trauma of shoulder ( Dislocation, Fracture of shoulder and rotator cuff injuries). 2. Subjects who are suffering from other systemic illness along with Primary Adhesive Capsulitis of shoulder joint. 3. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Reduction in SPADI score from baseline to the end of three months of homoeopathic treatmentTimepoint: Reduction in SPADI score from baseline to the end of three months of homoeopathic treatment

Secondary

MeasureTime frame
Reduction in pain & disability. Improvement in quality of life. Time taken for symptom relief.Timepoint: Once in 15 days for first three months followed by every once in a month for next three months

Countries

India

Contacts

Public ContactDr RAKSHITA

Government homoeopathic medical College and hospital

drpraveenmj@gmail.com7204172906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026